A number of other research firms also recently issued reports on SREN. JPMorgan Chase & Co. set a CHF 104 price target on shares of Swiss Re and gave the company a buy rating in a research report on Monday, October 9th. Deutsche Bank set a CHF 104 price target on shares of Swiss Re and gave the company a buy rating in a research report on Monday, October 9th. Barclays set a CHF 99 price target on shares of Swiss Re and gave the company a buy rating in a research report on Wednesday, October 25th. DZ Bank reiterated a buy rating on shares of Swiss Re in a research report on Thursday, November 2nd. Finally, Morgan Stanley set a CHF 108 price target on shares of Swiss Re and gave the company a buy rating in a research report on Monday, November 6th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the stock. Swiss Re currently has a consensus rating of Hold and a consensus target price of CHF 96.84.
Shares of Swiss Re (SREN) opened at CHF 94.46 on Wednesday. The company has a market cap of $32,780.00 and a PE ratio of 12.08. Swiss Re has a 12-month low of CHF 81.65 and a 12-month high of CHF 95.30.
TRADEMARK VIOLATION WARNING: “Swiss Re (SREN) Given a CHF 96 Price Target by Credit Suisse Group Analysts” was originally reported by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://baseballnewssource.com/markets/swiss-re-sren-given-a-chf-96-price-target-by-credit-suisse-group-analysts/1847523.html.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.